Latest in Version Novo Nordisk's
Sort by
5 items
-
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.CNBC - 16h -
FDA: Knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetesABC News - 5d -
Why Democrats’ Version of ‘Stop the Steal’ Isn’t Taking Off
A movement by some Democratic voters to investigate the results of the 2024 presidential election mirrors a push by Republicans in 2020. But it’s struggling.The New York Times - 5d -
European markets open higher in shortened session ahead of Christmas; Novo Nordisk resumes recovery
European stocks edged higher at the open on Tuesday.CNBC - 20h -
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza
The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.NBC News - 1d